FDA
approval
· 2022-01-25
FDA Approved: VYLIBRA — Supplemental Application (Afaxys Pharma, LLC)
Summary
FDA approved a supplemental application for VYLIBRA (norgestimate and ethinyl estradiol) from Afaxys Pharma, LLC, expanding its labeling for this oral contracep…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for VYLIBRA (NORGESTIMATE AND ETHINYL ESTRADIOL)